A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLC

Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC

NCT04416633 ·Status: COMPLETED ·Phase: PHASE4

First Real-world Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy

NCT03798535 ·Status: COMPLETED

Durvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma (LCNEC)

NCT06418087 ·Status: RECRUITING ·Phase: PHASE2

Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer

NCT03519971 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung Cancer

NCT06564870 ·Status: ACTIVE_NOT_RECRUITING

Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

NCT00651508 ·Status: COMPLETED ·Phase: PHASE2

Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer

NCT03030131 ·Status: TERMINATED ·Phase: PHASE2

A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil

NCT06008353 ·Status: ACTIVE_NOT_RECRUITING

Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

NCT04642469 ·Status: COMPLETED ·Phase: PHASE3

A Real-world Study of Durvalumab for Lung Cancer in China

NCT04672759 ·Status: UNKNOWN

Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous (NSCLC)

NCT03319316 ·Status: WITHDRAWN ·Phase: PHASE2

Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer

NCT05034133 ·Status: UNKNOWN ·Phase: PHASE2

Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC

NCT03822351 ·Status: COMPLETED ·Phase: PHASE2

IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer

NCT04854590 ·Status: COMPLETED

Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

NCT03999710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

1st Line Durvalumab in PS 2 NSCLC Patients

NCT03620669 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC

NCT05246514 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Chemo-immunotherapy, Hypo-fractionated RT and Maintenance Immunotherapy for Stage III NSCLC.

NCT05128630 ·Status: RECRUITING ·Phase: PHASE2

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

NCT04716946 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study of Durvalumab or Durvalumab Plus Chemotherapy in Kras Mutation Positive and PD-L1 High (≥ 50%) NSCLC Patients

NCT04470674 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer

NCT04905316 ·Status: COMPLETED ·Phase: PHASE2

Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer

NCT05507593 ·Status: UNKNOWN ·Phase: PHASE1

Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLC

NCT05910034 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)

NCT04449861 ·Status: COMPLETED ·Phase: PHASE3

Durvalumab in Combination With Standard Chemotherapy of Patients With Extensive Stage Small Cell Lung Cancer

NCT05761977 ·Status: UNKNOWN